<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Drug Development

Community    Leukemia    Clinical Research    Drug Development

Presentation to Colorado Legislature Committee Will Highlight Breakthrough Research in Leukemia Treatment

University of Colorado (CU) Cancer Center researchers have been on the leading edge of developing new therapies for leukemia. One of the most recent breakthrough therapies has been the development of venetoclax, a B-cell lymphoma-2 inhibitor, that that has shown profound results for adults with acute myeloid leukemia (AML) and has become a standard of care for patients with this disease all over the world.


Author Rachel Sauer | Publish Date February 24, 2022
Full Story

Cancer    AstraZeneca    Drug Development

CU Cancer Center leaders visit AstraZeneca to discuss speeding drug development efforts

AstraZeneca is pharmaceutical company committed to developing novel anti-cancer drugs. The University of Colorado Cancer Center is one of the fastest-growing academic cancer research centers in the United States, with hundreds of scientists and doctors working to better understand the disease. Recently, CU Cancer Center leaders visited the AstraZeneca Research and Development Campus in Gaithersburg, Maryland to discuss how a handshake between CU’s academia and AZ’s industry could help both take steps toward the ultimate goal: speeding the delivery of new drugs to cancer patients who need them.


Author Cancer Center | Publish Date April 18, 2019
Full Story

CU Cancer Center In the News

Dermatology Times

Sun Bus Helps Bust Melanoma Misconceptions, Provide Screenings

news outletDermatology Times
Publish DateMay 23, 2022

Run by the Colorado Melanoma Foundation, the Sun Bus has provided more than 3,500 free skin cancer screenings throughout the central and southwestern United States. Along the way, providers are learning about melanoma misconceptions.

Full Story
Forbes

University Of Colorado to Invest $200 Million in New Regenerative Medicine Institute

news outletForbes
Publish DateMay 13, 2022

The University of Colorado Anschutz Medical Campus has announced that it will make a $200 million investment over the next five years to create the Gates Institute, a research and treatment center that will focus on the development of new regenerative, cellular, and gene therapies for a variety of serious illnesses.

Full Story
Mirage News

Research Reveals How Tumor Cells Use Mitochondria to Keep Growing

news outletMirage News
Publish DateMay 10, 2022

In initial research recently published in the journal Molecular Cancer Research, Cecilia Caino, PhD, and her co-investigators discovered that tumor cells use mitochondria to control their growth and detect stress that can destroy a tumor cell if it is not controlled.

Full Story
Science News for Students

Like Bloodhounds, Worms Are Sniffing Out Human Cancers

news outletScience News for Students
Publish DateMay 09, 2022

Lung cancer cells seem to smell yummy to one species of little worm. Now, scientists are using that allure to build a squirmy new tool to detect cancer.

Full Story